RecruitingNot ApplicableNCT05556759

Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty

Anterior Iliopsoas Muscle Space Block Versus Supra-Iliac Anterior Quadratus Lumborum Block for Analgesia in Total Hip Arthroplasty: A Randomized Controlled Trial


Sponsor

Zagazig University

Enrollment

72 participants

Start Date

Sep 30, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Approximately 1.66 million hip fractures happen in a year worldwide. About 95% of these fractures happen in individuals older than 60 years. Surgical treatment involving THA is considered the best option for patients with hip fractures and those with degenerative changes in the hip joint, especially in the elderly, however, it is associated with moderate to severe postoperative pain. Pain is one of the main factors limiting ambulation, increasing the risk of thromboembolism by immobility, and causing metabolic changes that affect other systems. Therefore, individualized pain management with the use of appropriate analgesia techniques is of paramount importance. Moreover, early intervention of rehabilitation aiming at a better postoperative recovery may reduce the length of hospital stay and return to daily. Effective pain management is one of the crucial components of enhanced recovery after surgery (ERAS). Numerous regional anesthetic techniques have been used to provide analgesia following THA, including intrathecal morphine, epidural analgesia, fascia iliaca block, lumber plexus block, sacral plexus block, and local infiltration analgesia, however, each of these techniques has specific limitations that prevent them from being the analgesic technique of choice for THA. Up to investigators' knowledge, there is no study done to compare the supra-iliac approach to the anterior QL block versus the Anterior iliopsoas muscle space block as pre-emptive analgesia in patients undergoing THA under general anesthesia


Eligibility

Min Age: 50 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of nerve block injections used to control pain after total hip replacement surgery. Hip replacement is one of the most common major surgeries, and good pain control afterward is essential for recovery. The study compares an anterior iliopsoas muscle space block versus a supra-iliac anterior quadratus lumborum block — both injected under ultrasound guidance — to see which provides better and longer-lasting pain relief with fewer side effects. You may be eligible if: - You are between 50 and 80 years old - You are scheduled for an elective total hip replacement under general anesthesia - Your BMI is 30 kg/m² or less - You are classified as ASA I-III You may NOT be eligible if: - You are allergic to local anesthetic medications - You have a skin lesion or infection at the injection site - You have a bleeding disorder, sepsis, liver disease, or psychiatric disorder - You have a pre-existing neurological deficit in your lower extremity - You have chronic pain or regularly take analgesic medications - You have cognitive dysfunction or mental illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREcontrol

patient will be operated under general anesthesia

PROCEDUREIPS

patients will receive ultrasound-guided anterior IPS block with 30 ml of bupivacaine 0.25% followed by general anesthesia.

PROCEDURESupra-iliac QL

patients will receive ultrasound-guided supra-iliac anterior QL block with 30 ml of bupivacaine 0.25% followed by general anesthesia.


Locations(1)

Faculty of medicine, zagazig university

Zagazig, Alsharqia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05556759


Related Trials